news aktuell GmbH

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

7.12.2021 14:28:03 CET | news aktuell GmbH | Press release

Share
Darmstadt, 7 December 2021 – R-Biopharm, an international specialist in clinical diagnostics, announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”). R-Biopharm will now work to resume the sale of the product in the UK.

RIDA®GENE Flu & SARS-CoV-2 test is a multiplex real-time RT-PCR for the direct qualitative detection and differentiation of Flu A/Flu B and coronavirus (SARS-CoV-2) RNA in human nasal/throat swabs from persons with signs and symptoms of respiratory infection. It is intended for professional use for example in hospital laboratories, reference laboratories, private laboratories, or public laboratories. The RIDA®GENE Flu & SARS-CoV-2 multiplex test targets the M gene/NP1 gene of the virus for Influenza A/B and the E gene and RdRpgene in all currently known variants and mutations of the COVID 19 virus.

Only validated products, or products on the temporary protocol, can be sold in the UK after 31 October 2021. Jason Baggaley, Sales Manager of R-Biopharm for Great Britain, commented: “We are proud that our RIDA®GENE Flu & SARS-CoV-2 test was approved and added to the CTDA register and our customers will continue to be able to distinguish between the flu and an infection with the Corona virus.“

 Press contact:

Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com 
https://r-biopharm.com/news-press

R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt, Germany

Tel.: 0 61 51 - 81 02-538
Mobile: 0 160 - 55 273 60
Fax: 0 61 51 - 81 02-40

Email: s.feiler@r-biopharm.de 

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Bikeleasing Group announces strategic investment in New Zealand’s leading bike leasing company Workride / Next strategic step in cross-continental expansion29.7.2026 14:18:02 CEST | Press release

The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.

Dr. Gunther von Hagens, Inventor of Plastination & Creator of BODY WORLDS, Has Passed Away27.7.2026 14:31:59 CEST | Press release

Heidelberg/Germany, July 27, 2026—It is with deep sadness that the family and the Institute for Plastination announce the passing of Dr. Gunther von Hagens, inventor of Plastination and creator of the BODY WORLDS exhibitions. He died on July 24, 2026, at the age of 81. Gunther von Hagens fundamentally transformed the field of anatomy. Through Plastination—the preservation techni­que he invented in 1977—he created an entirely new perspective of the human body for medical education, science and the general public. He made the complexity, vulnerability and beauty of the human body—previously reserved for the dissection room and anatomical textbooks –directly accessible to the wider public. Together with his wife and curator, Dr. Angelina Whalley, Gunther von Hagens created BODY WORLDS, one of the most successful exhibitions in the world. Since its debut, the exhibition has been visited by more than 58 million people. BODY WORLDS made anatomy publicly accessible, encouraged reflection on h

TOSYALI secured 187 million Euro financing from Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) for its first phase of 1.2 GW solar investment23.7.2026 15:25:09 CEST | Press release

TOSYALI continues to accelerate its energy transition by securing long term international financing for supporting its decarbonization agenda and sustainability investments. The company has signed Export Finance Buyer Credit Agreements worth 187 million euros with BBVA, under Spanish Export Credit Agency Cesce’s cover, for Osmaniye and Niğde Projects in its first phase of solar power plant (SPP) investments with total capacity of 1.2 GW.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye